Antimicrobial Therapy in Community-Acquired Pneumonia in Children

Overview

Journal Curr Infect Dis Rep

Specialty Infectious Diseases

Date 2018 Sep 22

PMID 30238375

Citations 4

Authors

Samriti Gupta

Rakesh Lodha

S K Kabra

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Empirical antibiotic therapy remains the cornerstone of treatment in community-acquired pneumonia (CAP). However, the best option for empirical antibiotics for treatment on an ambulatory basis, as well as in those requiring hospitalization, is still unclear. This review tries to answer the question regarding the most appropriate antibiotics in different settings in children with CAP as well as duration of therapy.

Recent Findings: Recent studies have provided insights regarding use of oral antibiotics in children with mild to moderate CAP, and severe CAP with lower chest retractions but no hypoxia. In view of rapidly emerging resistance among various causative pathogens, several new drugs have been currently approved, or are under trial for CAP in children. Current knowledge suggests that the choice of antibiotics for ambulatory treatment of CAP is oral amoxicillin with a duration of 3-5 days. Children with CAP with lower chest retractions but no hypoxia can be treated with oral amoxicillin. Severe pneumonia can be treated with intravenous antibiotics consisting of penicillin/ampicillin with or without an aminoglycoside. Several new drugs have been developed and approved for use in CAP caused by multidrug-resistant organisms, but these should be used judiciously to avoid emergence of further resistance. Future research is needed regarding the safety and efficacy of newer drugs in children.

Citing Articles

Improving Antibiotic Use in Argentine Pediatric Hospitals: A Process Evaluation Using Normalization Process Theory.

Roberti J, Jorro-Baron F, Ini N, Guglielmino M, Rodriguez A, Echave C Pediatr Qual Saf. 2025; 10(1):e788.

PMID: 39776948 PMC: 11703432. DOI: 10.1097/pq9.0000000000000788.

Comparison of Short-Term Versus Long-Term Antibiotic Therapy Among Severe Cases of Pneumonia: A Prospective Observational Study Among Children.

Potpalle D, Gada S, Devaguru A, Behera N, Dinesh Eshwar M Cureus. 2023; 15(2):e35298.

PMID: 36968915 PMC: 10037924. DOI: 10.7759/cureus.35298.

Efficacy and safety of Chinese herbal medicine for pneumonia convalescence in children: A systematic review and meta-analysis.

Guo J, Bai X, Zhang H, Zhang N, Liang J, Guo Z Front Pharmacol. 2022; 13:956736.

PMID: 36120373 PMC: 9479002. DOI: 10.3389/fphar.2022.956736.

A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings.

Gatti M, Cojutti P, Campoli C, Caramelli F, Corvaglia L, Lanari M Front Pharmacol. 2021; 12:755075.

PMID: 34646143 PMC: 8502823. DOI: 10.3389/fphar.2021.755075.

The Association of Antibiotic Duration With Successful Treatment of Community-Acquired Pneumonia in Children.

Same R, Amoah J, Hsu A, Hersh A, Sklansky D, Cosgrove S J Pediatric Infect Dis Soc. 2020; 10(3):267-273.

PMID: 32525203 PMC: 8023315. DOI: 10.1093/jpids/piaa055.

References

Mackenzie G . The definition and classification of pneumonia. Pneumonia (Nathan). 2017; 8:14. PMC: 5471962. DOI: 10.1186/s41479-016-0012-z. View

Yu V, Chiou C, Feldman C, Ortqvist A, Rello J, Morris A . An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003; 37(2):230-7. DOI: 10.1086/377534. View

Liu L, Johnson H, Cousens S, Perin J, Scott S, Lawn J . Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379(9832):2151-61. DOI: 10.1016/S0140-6736(12)60560-1. View

Rudan I, OBrien K, Nair H, Liu L, Theodoratou E, Qazi S . Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013; 3(1):010401. PMC: 3700032. DOI: 10.7189/jogh.03.010401. View

Lodha R, Kabra S, Pandey R . Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev. 2013; (6):CD004874. PMC: 7017636. DOI: 10.1002/14651858.CD004874.pub4. View

Lodha R, Randev S, Kabra S . Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review. Indian Pediatr. 2016; 53(6):489-95. DOI: 10.1007/s13312-016-0878-0. View

Breuer O, Blich O, Cohen-Cymberknoh M, Averbuch D, Kharasch S, Shoseyov D . Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy. Pediatr Pulmonol. 2015; 50(5):495-502. DOI: 10.1002/ppul.23159. View

Galli L, Montagnani C, Chiappini E, De Martino M . Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance. Acta Paediatr. 2013; 102(465):25-33. DOI: 10.1111/apa.12503. View

Singh J, Sundaresan S, Manoharan A, Shet A . Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review. Vaccine. 2017; 35(35 Pt B):4501-4509. DOI: 10.1016/j.vaccine.2017.06.079. View

10.

Lee Y, Hong S, Choi S, Im W, Yong D, Lee K . In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study. Ann Lab Med. 2015; 35(5):523-30. PMC: 4510506. DOI: 10.3343/alm.2015.35.5.523. View

11.

Wunderink R . How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?. Infect Dis Clin North Am. 2013; 27(1):177-88. DOI: 10.1016/j.idc.2012.11.006. View

12.

Nannini E, Corey G, Stryjewski M . Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies. Expert Rev Anti Infect Ther. 2012; 10(8):847-54. DOI: 10.1586/eri.12.81. View

13.

Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M . Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ. 2008; 336(7635):80-4. PMC: 2190277. DOI: 10.1136/bmj.39421.435949.BE. View

14.

Liu Y, Zhang Y, Wu J, Zhu D, Sun S, Zhao L . A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia. J Microbiol Immunol Infect. 2016; 50(6):811-820. DOI: 10.1016/j.jmii.2015.09.005. View

15.

Sidal M, Oguz F, Unuvar A, Sarbat G, Neyzi O . Trial of co-trimoxazole versus procaine penicillin G and benzathin penicillin + procaine penicillin G in the treatment of childhood pneumonia. J Trop Pediatr. 1994; 40(5):301-4. DOI: 10.1093/tropej/40.5.301. View

16.

Sun H, Ting L, Machineni S, Praestgaard J, Kuemmell A, Stein D . Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects. Antimicrob Agents Chemother. 2016; 60(12):7431-7435. PMC: 5119026. DOI: 10.1128/AAC.01393-16. View

17.

Jinno S, Jacobs M . Pneumonia Due to Drug-Resistant Streptococcus pneumoniae. Curr Infect Dis Rep. 2012; 14(3):292-9. DOI: 10.1007/s11908-012-0260-x. View

18.

Awasthi S, Agarwal G, Kabra S, Singhi S, Kulkarni M, More V . Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial. PLoS One. 2008; 3(4):e1991. PMC: 2292255. DOI: 10.1371/journal.pone.0001991. View

19.

Sicot N, Khanafer N, Meyssonnier V, Dumitrescu O, Tristan A, Bes M . Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia--results of a prospective observational study. Clin Microbiol Infect. 2012; 19(3):E142-8. DOI: 10.1111/1469-0691.12022. View

20.

Campbell H, Byass P, Forgie I, Oneill K, Greenwood B . Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet. 1988; 2(8621):1182-4. DOI: 10.1016/s0140-6736(88)90244-9. View